These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28126538)
1. Rethinking Autoantibody Signature Panels for Cancer Diagnosis. Campa MJ; Gottlin EB; Herndon JE; Patz EF J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538 [TBL] [Abstract][Full Text] [Related]
2. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928 [TBL] [Abstract][Full Text] [Related]
3. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432 [TBL] [Abstract][Full Text] [Related]
4. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Patel K; Farlow EC; Kim AW; Lee BS; Basu S; Coon JS; DeCresce D; Thimothy L; Walters KA; Fhied C; Chang C; Chen SH; Faber LP; Bonomi P; Liptay MJ; Borgia JA Int J Cancer; 2011 Jul; 129(1):133-42. PubMed ID: 20824709 [TBL] [Abstract][Full Text] [Related]
6. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer. Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397 [TBL] [Abstract][Full Text] [Related]
7. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826 [TBL] [Abstract][Full Text] [Related]
8. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies. Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms]. Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573 [No Abstract] [Full Text] [Related]
10. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
11. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer. Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386 [TBL] [Abstract][Full Text] [Related]
12. A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer. Shan Q; Lou X; Xiao T; Zhang J; Sun H; Gao Y; Cheng S; Wu L; Xu N; Liu S Cancer Lett; 2013 Jan; 328(1):160-7. PubMed ID: 22922091 [TBL] [Abstract][Full Text] [Related]
13. An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer. Wu WB; Yie SM; Ye SR; Xie K; Zhang JB; Cao M; Chen J; He X; Ma XL; Zhang J Ann Thorac Surg; 2018 Jun; 105(6):1664-1670. PubMed ID: 29453962 [TBL] [Abstract][Full Text] [Related]
14. Early detection of NSCLC with scFv selected against IgM autoantibody. Pedchenko T; Mernaugh R; Parekh D; Li M; Massion PP PLoS One; 2013; 8(4):e60934. PubMed ID: 23585862 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
16. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer. Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients]. Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487 [TBL] [Abstract][Full Text] [Related]
18. [Detecting EGFR autoantibodies in serums of NSCLC patients with peptide array]. Li Y; Yue W; Wang Y; Zhang L; Gu M; Xu S Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):727-30. PubMed ID: 20673491 [TBL] [Abstract][Full Text] [Related]
19. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer. Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270 [TBL] [Abstract][Full Text] [Related]
20. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea. Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]